Document and Entity Information [Abstract] Document and Entity Information [Abstract] Statement [Table] Legal Entity [Axis] Entity [Domain] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Period End Date Trading Symbol Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Voluntary Filers Entity Well Known Seasoned Issuer Entity Public Float Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] ASSETS Current Assets Cash and cash equivalents Marketable securities Restricted cash Accounts receivable - project revenue and reimbursable Prepaid expenses & other current assets Total Current Assets Property Plant and Equipment -net Other Assets Patent costs - net Total Assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Accounts payable and accrued liabilities Total Current Liabilities Commitments and contingencies Stockholders' Equity Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding and 15,057,243 shares Additional paid-in capital - stock and stock equivalents Accumulated Deficit Common shares reserved for issuance Total Stockholders' Equity Total Liabilities and Stockholders' Equity Preferred Stock, Par Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Common stock reserved for issuance Common stock reserved for issuance Statement of Operations [Abstract] Revenue: Consulting Revenue Cost of Consulting Services Provided Gross Margin Operating Expenses General and administrative Research and development expenses Total Operating Expenses Operating Loss Other Income and (Expenses) Investment income Other income (expenses) Total Other Income and (Expenses) Net loss before income taxes Income taxes Net loss Net Loss Per Common Share, Basic and Diluted Weighted Average Number of Shares Outstanding Statement of Cash Flows [Abstract] Operating Activities: Net Loss Adjustments to reconcile net loss from operations to net cash used Stock-based compensation Depreciation and amortization Loss on marketable securities Changes in non-cash operating working capital items: Accounts receivable - fees and reimbursable project costs Prepaid expenses and other assets Accounts payable, accrued liabilities and other current Net Cash Used In Operating Activities Investing Activities: Proceeds from the sale of marketable securities Purchase of Marketable securities Patent costs Property and equipment Net Cash Provided by (Used In) Investing Activities Financing Activities: Net proceeds from the issuance of common stock Stock offering costs Redemption of common stock into treasury stock Restricted cash Net Cash Provided by Financing Activities Net Increase In Cash and Cash Equivalents Cash and Cash Equivalents, Beginning of Year Cash and Cash Equivalents, End of Year Supplemental Disclosure of Cash Flow Information: Cash paid during the year: Cash paid during the period Interest paid Income taxes paid Non-Cash Financing Activity Equity Components [Axis] Equity Components [Domain] Common Stock [Member] Additional Paid-In Capital [Member] Deficit [Member] Stock Commited Future Issuance [Member] Stock Commited Future Issuance [Member] Statement of Stockholders Equity [Abstract] Beginning Balance Beginning Balance (Shares) Shares Issued (Shares) Shares issued-stock grants Shares issued-stock grants (Shares) Proceeds from the sale of common stock - net of offering costs Proceeds from the sale of common stock - net of offering costs Proceeds from the sale of common stock - net of offering costs (Shares) Proceeds from the sale of common stock - net of offering costs (Shares) Shares Issued (Shares) (SharesIssued) Net loss for the year Stock-based compensation Stock-based compensation (Shares) Common Stock issued - registered offering and exerise of stock warrants - net of offering costs Common Stock issued - registered offering and exerise of stock warrants - net of offering costs Common Stock issued - registered offering and exerise of stock warrants - net of offering costs (Shares) Common Stock issued - registered offering and exerise of stock warrants - net of offering costs (Shares) Ending Balance Ending Balance (Shares) Notes to Financial Statements [Abstract] Notes to Financial Statements [Abstract] Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations [Text Block] Net Loss Per Share [Text Block] Scenario [Axis] Scenario [Domain] Approximations [Member] Approximations Accounts Receivable -Project Revenue and Reimbursable Project Costs [Text Block] Prepaid Expenses & Other Current Assets [Text Block] Prepaid Expenses & Other Current Assets [Text Block] Patents and Other Assets [Text Block] Accounts Payable and Accrued Liabilities [Text Block] Valuation Allowance by Deferred Tax Asset [Axis] Deferred Tax Asset [Domain] Deferred Tax Asset Amount [Member] Deferred Tax Asset Amount Income Taxes [Text Block] Commitments and Contingencies [Text Block] Research and Development Costs [Text Block] Stockholders' Equity [Text Block] Business Segment Results [Text Block] Subsequent Events [Text Block] Basis of Consolidation [Policy Text Block] BasisOfPresentation Use of Estimates and Assumptions [Policy Text Block] Significant Estimates [Policy Text Block] Significant Estimates Company Liquidity, Certain Risks, Uncertainties and Concentrations [Policy Text Block] Revenue Recognition [Policy Text Block] Consulting Business Segment [Policy Text Block] Consulting Business Segment Technology Business Segment [Policy Text Block] Technology Business Segment Stock-Based Compensation [Policy Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Cash and Cash Equivalents, Restricted Cash and Marketable Securities [Policy Text Block] Trade Accounts Receivable [Policy Text Block] Income Taxes [Policy Text Block] Property, Plant and Equipment [Policy Text Block] Foreign Currency [Policy Text Block] Patents and Legal Costs [Policy Text Block] Impairment of long-lived assets [Policy Text Block] Research, Development and Related Expenses [Policy Text Block] Segment Reporting, Policy [Policy Text Block] Commitments and Contingencies [Policy Text Block] Retirement 401(K) Plan [Policy Text Block] Recent Accounting Pronouncements [Policy Text Block] Business Combinations and Other Purchase of Business Transactions, Policy [Policy Text Block] Basis of presentation [Policy Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] Schedule of Warrants Outstanding [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Share-based Compensation, Activity [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Financial Instrument [Axis] Financial Instruments [Domain] Doubleline Total Return Bond Fund [Member] Doubleline Total Return Bond Fund Vanguard Wellesley Income Fund [Member] Vanguard Wellesley Income Fund Vanguard High Yield Corp Investor Fund [Member] Vanguard High Yield Corp Investor Fund Vanguard GNMA Investor Fund [Member] Vanguard GNMA Investor Fund Vanguard Short Term Investment Grade Investor [Member] Vanguard Short Term Investment Grade Investor Range [Axis] Range [Domain] Minimum [Member] Maximum [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Corporate Credit Card and Daily ACH Transaction Limit [Member] Corporate Credit Card and Daily ACH Transaction Limit Value of nuclear science and technology center Value of nuclear science and technology center Extention of fuel cycle length Extention of fuel cycle length Power output increase based on future potential reveunes Power output increase based on future potential reveunes Operating cycle length Operating cycle length Maximum increase in power output Maximum increase in power output Metallic fuel power uprate percentage Metallic fuel power uprate percentage Operating cycle length - Westinghouse-type Operating cycle length - Westinghouse-type Stock based compensation Federally insured cash limit Cash and Cash Equivalents, at Carrying Value Restricted Cash Letters of credit outstanding Letters of credit outstanding Marketable Securities Mutual Funds Unrealized Gain (Loss) on Securities Cost basis of investments Unrealized gain loss from financial institutions Unrealized gain loss from financial institutions Valuation allowance Valuation allowance More likely than not threshold More likely than not threshold Percentage of cost of consulting from one firm Percentage of cost of consulting from one firm Amortization period for patents Research and Development Expense Major Customers [Axis] Name of Major Customer [Domain] ENEC and FANR Projects [Member] ENEC Project FANR [Member] FANR Lloyd Register Contract [Member] Lloyd Register Contract Accounts Receivable Portion of accounts receivable Portion of accounts receivable Major customer revenue percentage Major customer revenue percentage Unbilled receivable Foreign Currency Transaction Gain (Loss) Travel costs and reimbursable costs Travel and other reimbursable expenses included in accounts receivable Travel and other reimbursable expenses included in accounts receivable Concentration Risk, Percentage Prepaid Expense and Other Assets, Current Security Deposit Estimated useful life of patents and other intangible assets Capitalized costs for patents Capitalized costs for patents Investment in patents Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate Deferred Tax Assets, Operating Loss Carryforwards Valuation allowance Change in valuation allowance Lease agreement [Axis] Lease agreement Lease agreement [Domain] Lease agreement Moscow Office [Member] Moscow Office Virginia Office [Member] Virginia Office Litigation Case [Axis] Litigation Case [Domain] Fairfax County Complaint 1 [Member] Fairfax County Complaint 1 Fairfax County Complaint 2 [Member] Fairfax County Complaint 2 Operating lease term Operating lease term Monthly rental fees Deferred Rent Credit Rent expense Compensatory damages sought Research and Development Agreement [Axis] Research and Development Agreement [Domain] Task Order No.1 with Texas AM University [Member] Task Order 1 with Texas AM University Research and development costs Research and development costs Consulting agreement monthly payments Consulting agreement monthly payments Amount due upon execution Amount due upon execution Amount due on December 15, 2012 Total amount of payments made Amount due on delivery of the final report Professional Services Agreement Award Type [Axis] Award Type [Domain] Stock Compensation Plan [Member] Maximum restricted shares granted [Member] Maximum restricted shares granted [Member] Maximum number of shares in respect to stock options [Member] Maximum number of shares in respect to stock options [Member] Maximum restricted shares granted to one person [Member] Maximum restricted shares granted to one person [Member] Stock Options Vested [Member] Stock Options Vested Stock-based compensation [Member] Stock-based compensation [Member] Restricted Stock [Member] Restricted Stock Units [Member] Warrants [Member] Employee Stock Option [Member] Stock and Stock Equivalents [Member] Stock and Stock Equivalents Option [Member] Equity Transaction [Axis] Equity Transaction [Axis] Equity Transaction [Domain] Equity Transaction [Domain] Issuance of 255,202 non-qualified 10 year options [Member] Issuance of 255,202 non-qualified 10 year options Issuance of 1,579,415 non-qualified 5-10 year options [Member] Issuance of 1,667,181 non-qualified 8-10 year options Unregistered Securities [Member] Unregistered Securities Registered Direct Offering and Outstanding Warrants [Member] Registered Direct Offering and Outstanding Warrants Issuance of 191,947 non-qualified 5-10 year options [Member] Issuance of 211,303 non-qualified 5-10 year options May 5, 2014 Stock Options Granted [Member] May 5, 2014 Stock Options Granted November 12, 2014 Offering [Member] November 12, 2014 Offering Issued to Investors on July 28, 2010 [Member] Issued to Investors on July 28, 2010 Issued to Investors on October 25, 2013 [Member] Issued to Investors on October 25, 2013 Issued to Investors on November 17, 2014 [Member] Issued to Investors on November 17, 2014 Related Party Transactions, by Related Party [Axis] Related Party [Domain] Chief Executive Officer [Member] Directors, Officers and Employees [Member] Common Stock, Shares Authorized Common Stock, Shares, Outstanding Class of Warrant or Right, Outstanding Number of options outstanding Unvested Shares Issued but unvested restricted stock Issued but unvested restricted stock Total stock and stock equivalents outstanding Total stock and stock equivalents outstanding Common Stock, Capital Shares Reserved for Future Issuance Number of options vested and expected to vest outstanding Stock option expense Non-qualified stock options Non-qualified stock options Contractural lives Lower Limit Upper Limit Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value Unrecognized compensation costs Unrecognized compensation costs Expected compensation cost Expected compensation cost Weighted average recognition period Weighted average recognition period Restricted stock grants estimated forfeiture amount Restricted stock grants estimated forfeiture amount Share based compensation Equity Issuance, Per Share Amount Common Stock issued Proceeds from Issuance of Common Stock Common stock and warrants sold Common stock and warrants sold Common stock to be purchased in the Offering Exercisable term Shares of common stock to be purchased by fixed combination Shares of common stock to be purchased by fixed combination Purchase price of fixed combination Purchase price of fixed combination Warrant exercise price Maximum common stock ownership to be eligible for exercise of warrants Maximum common stock ownership to be eligible for exercise of warrants Net proceeds from the Offering received after payments of fees and expenses Net proceeds from the Offering received after payments of fees and expenses Amount allocated from the Offering to common stock Amount allocated from the Offering to warrants Volitility rate Risk-free interest rate Dividend yield Expected term Strike Price Strike Price Stock options granted Fair value of stock options granted Fair value of stock options granted Fair market value on measurement date Fair market value on measurement date Pre-vesting forfeiture rate Pre-vesting forfeiture rate Value of vested awards Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] November 2014 Offering [Member] November 2014 Offering Warrant [Member] Warrant Amount Weighted Average Number of shares outstanding Basic and diluted net loss per share Trade payables Accrued expenses and other Accrued payroll liabilities Total Capitalized start up costs Capitalized start up costs Share based compensation Share based compensation Net operating loss carry-forward Less: valuation allowance Deferred Tax Assets, Net, Total Year ending - December 31, 2014 Total minimum lease payments Warrants Outstanding Exercise price Beginning of Period Weighted Average Exercise Price Beginning of the Year Weighted Average Fair Value Stock Options Beginning of the Year Weighted Average Exercise Price Stock Options Granted Weighted Average Fair Value Stock Options Granted Weighted Average Fair Value Stock Options Granted Exercised Weighted Average Exercise Price Weighted Average Exercise Price Weighted Average Fair Value Stock Options Exercised Weighted Average Fair Value Stock Options Exercised Forfeited Weighted Average Exercise Price Stock Options Forfeited Weighted Average Fair Value Stock Options Forfeited Weighted Average Fair Value Stock Options Forfeited Expired Weighted Average Exercise Price Stock Options Expired Weighted Average Fair Value Stock Options Expired Weighted Average Fair Value Stock Options Expired End of year Weighted Average Exercise End of Year Weighted Average Fair Value Stock Options End of Year Weighted Average Fair Value Stock Options End of Year Options exercisable Weighted Average Exercise Price Options exercisable Weighted Average Fair Value Options exerciseable Weighted Average Fair Value Options exerciseable Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Range 1 [Member] Range 1 Range 2 [Member] Range 2 Range 3 [Member] Range 3 Range 4 [Member] Range 4 Exercise price lower range limit Exercise price upper range limit Weighted Average Remaining Contractural Life - Years Weighted Average Remaining Contractural Life - Years Weighted Average Exercise Price Stock Options Outstanding Number of Awards Vested Weighted Average Exercise Price Weighted Average Remaining Contractual Life of Stock Options Vested Total awards outstanding beginning of the period Weighted average grant date fair value total awards outstanding beginning of the period Units granted Weighted average grant date fair value units Granted Units Exercised/Released Units Exercised/Released Weighted average grant date fair value units exercised/released Weighted average grant date fair value units exercised/released Units vested Total units vested Total units vested Weighted average grant date fair value units Vested Units Cancelled/Forfeited Weighted average grant date fair value units Cancelled/Forfeited Total awards outstanding at end of period Total awards outstanding at end of period Weighted Average Grant Date Fair value, Total awards outstanding at end of period Weighted Average Grant Date Fair value, Total awards outstanding at end of period Weighted average grant date fair value total units non-vested Total units outstanding for the period Total units outstanding for the period Weighted average grant date fair value total units outstanding for the period Weighted average grant date fair value total units outstanding for the period Restricted stock units scheduled to vest in the next year Restricted stock units scheduled to vest in the next year Restricted stock units scheduled for vesting in the second year Restricted stock units scheduled for vesting in the second year Restricted stock units scheduled for vesting in the third year Restricted stock units scheduled for vesting in the third year Restricted stock units scheduled for vesting in the fourth year Restricted stock units scheduled for vesting in the fourth year Restricted stock units scheduled for vesting thereafter Restricted stock units scheduled for vesting thereafter Total outstanding restricted stock units scheduled to vest Total outstanding restricted stock units scheduled to vest Average risk-free interest rate Average expected life- years Expected volatility Expected dividends Stock-based Compensation [Axis] Stock-based Compensation Stock-based Compensation [Domain] Stock-based Compensation Shares of Common Stock Common Stock Amount Statement, Business Segments [Axis] Segment [Domain] Consulting [Member] Consulting Technology [Member] Technology Corporate and Eliminations [Member] Corporate and Eliminations Segment Reporting [Member] Segment Reporting Revenue Segment Profit - Pre Tax Total Assets Property Additions Interest Expense Depreciation Total Current Assets Total Assets Total Current Liabilities Total Stockholders' Equity Total Liabilities and Stockholders' Equity Gross Margin Total Operating Expenses Operating loss Total Other Income and Expenses Net loss before income taxes Net loss Loss on marketable securities Accounts receivable - fees and reimburseable project costs Prepaid expenses and other assets Net Cash Used In Operating Activities Purchase of marketable securities Patent costs Property and equipment Net Cash Provided by Investing Activities Stock offering costs Redemption of common stock into treasury stock Restricted cash (IncreaseDecreaseInRestrictedCash) Net Cash Provided by (Used In) Financing Activities Net Increase (Decrease) In Cash and Cash Equivalents Cash Paid During The Period [Abstract] Shares issued-stock grants Shares issued-stock grants (Shares) Proceeds From The Sale Of Common Stock Net Of Offering Costs Proceeds From The Sale Of Common Stock Net Of Offering Costs Shares Stock-based compensation Stock-based compensation (Shares) Shares Issued Registered Direct Offering Net Of Offering Costs Shares Issued Registered Direct Offering Net Of Offering Costs Shares Prepaid Expenses Other Current Assets [Text Block] Value Of Nuclear Science And Technology Centre Power Output Increase Based On Future Potential Reveunes Operating Cycle Length Maximum Increase In Power Output Based On Future Revenue Metallic Fuel Power Uprate Percentage Operating Cycle Length Westinghouse Type Federally insured cash limit Restricted Cash (RestrictedCashAndInvestments) Letter Of Credit Marketable Securities (MarketableSecurities) Percentage Of Cost Of Consulting From One Firm Amortization period for patents Portion Of Accounts Receivable Major Customer Revenue Percentage Concentration Risk, Percentage Prepaid Expense and Other Assets, Current Security Deposit Capitalized Costs For Patents Investment in patents Fairfax County Complaint One [Member] Fairfax County Complaint Two [Member] Monthly rental fees Compensatory damages sought Task Order One With Texas Am University [Member] Consulting Agreement Montly Payments Amount due on December 15, 2012 Total amount of payments made Amount due on delivery of the final report Professional Services Agreement Stockbased Compensation [Member] Issuance Of Two Five Five Two Zero Two Nonqualified One Zero Year Options [Member] Issuance Of One Five Seven Nine Four One Five Nonqualified Five One Zero Year Options [Member] Issuance Of One Nine One Nine Four Seven Nonqualified Five One Zero Year Options [Member] May Five Two Zero One Four Stock Options Granted [Member] November One Two Two Zero One Four Offering [Member] Issued To Investors On July Two Eight Two Zero One Zero [Member] Issued To Investors On October Two Five Two Zero One Three [Member] Issued To Investors On November One Seven Two Zero One Four [Member] Class of Warrant or Right, Outstanding Number of options outstanding Unvested Shares Number of options vested and expected to vest outstanding Equity Issuance, Per Share Amount Common Stock And Warrants Sold Common stock to be purchased in the Offering Exercisable term Shares Of Common Stock To Be Purchased By Fixed Combination Purchase Price Of Fixed Combination Warrant exercise price Maximum Common Stock Ownership To Be Eligible For Exercise Of Warrants Net Proceeds From The Offering Received After Payments Of Fees And Expenses Amount allocated from the Offering to common stock Amount allocated from the Offering to warrants Strike Price Stock options granted Share Based Compenation Weighted Average Fair Value Fair Market Value On Measurement Date Pre Vesting Forfeiture Rate Value of vested awards November Two Zero One Four Offering [Member] Warrant Amount [Member] Deferred Tax Assets Share Based Compensation Less: valuation allowance Deferred Tax Assets, Net, Total Year ending - December 31, 2014 Weighted Average Exercise Price Beginning of the Year Weighted Average Exercise Price Stock Options Granted Share Based Compensation Weighted Average Fair Value Stock Options Granted Exercised Share Based Compensation Weighted Average Exercise Price Stock Options Exercised Share Based Compensation Weighted Average Fair Value Stock Options Exercised Forfeited Weighted Average Exercise Price Stock Options Forfeited Share Based Compensation Weighted Average Fair Value Stock Options Forfeited Expired Weighted Average Exercise Price Stock Options Expired Share Based Compensation Weighted Average Fair Value Stock Options Expired Share Based Compensation Weighted Average Fair Value End Of Year Options exercisable Weighted Average Exercise Price Options exercisable Share Based Compensation Weighted Average Fair Value Options Exerciseable Range One [Member] Range Two [Member] Range Three [Member] Range Four [Member] Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term Weighted Average Exercise Price Weighted Average Remaining Contractual Life of Stock Options Vested Weighted average grant date fair value total awards outstanding beginning of the period Weighted average grant date fair value units Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Grant Date Fai Share Based Compensation Arrangement By Share Based Paymant Award Equity Instruments Other Than Options Vested Total Weighted average grant date fair value units Vested Weighted average grant date fair value units Cancelled/Forfeited Share Based Compensation Arrangement By Share Based Paymant Award Equity Instruments Other Than Options Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value Period Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Total Nonvested Number Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Total Nonvested Weighted Average Grant Date Fair Va Stockbased Compensation [Axis] Stockbased Compensation [Domain]